Syner-G is a Strategic Development & Delivery Partner™ to biopharma innovators. We bring together integrated scientific, regulatory, technical, and strategic consulting expertise across the development lifecycle. With a global reach of 400+ professionals across North America, Europe, and APAC, Syner-G is committed to collaborating with our clients to tackle the complexity of drug development and commercialization, merging scientific rigor, operational excellence, and transformative thinking to reduce risk, accelerate progress, and deliver inspiring outcomes that advance science to improve patient lives. To learn more, visit synergbiopharma.com.
| Website | https://www.synergbiopharma.com/ |
| Revenue | $67.5 million |
| Employees | 335 (1 on RocketReach) |
| Address | 100 Pennsylvania Avenue, Framingham, Massachusetts 01701, US |
| Industry | Pharmaceutical Manufacturing |
| Keywords | Cmc Consulting, Pharmaceutical Consulting, Regulatory Affairs, Regulatory Services, Pharma Consulting, Biopharmaceutical Services, Drug Development, Quality Assurance, Quality Control, Compliance Consulting, Contract Manufacturing, Drug Manufacturing, Technical Development, Clinical Development, Process Development, Medical Writing, Analytical Testing, It Solutions, Pharmaceutical It |
| Competitors | Roche, Pfizer, Amgen, Bristol Myers Squibb, Novartis, Gilead Sciences, AbbVie, Johnson & Johnson, Regeneron, Merck AH +39 more (view full list) |
Looking for a particular Syner-G BioPharma Group employee's phone or email?
Syner-G BioPharma Group Questions
The Syner-G BioPharma Group annual revenue was $67.5 million in 2026.
Ron Kraus is the CEO of Syner-G BioPharma Group.
1 people are employed at Syner-G BioPharma Group.
Syner-G BioPharma Group is based in Framingham, Massachusetts.
Top Syner-G BioPharma Group Employees
-
Ron Kraus
Chief Executive Officer at Syner-G BioPharma Group
Hingham, MA, US14
Related Companies
